Cericlamine

Cericlamine
Systematic (IUPAC) name
3-(3,4-Dichlorophenyl)-2-(dimethylamino)-2-methylpropan-1-ol
Clinical data
Routes of
administration		 Oral[1]
Pharmacokinetic data
Biological half-life 8 hours[1]
Identifiers
CAS Number
129162-62-5 (HCl) 112922-55-1
129162-62-5 (HCl)
ATC code None
PubChem CID 131074
ChemSpider 115890
Chemical data
Formula C12H17Cl2NO
Molar mass 262.17548 g/mol

Cericlamine (INN) (developmental code name JO-1017) is a potent and moderately selective serotonin reuptake inhibitor (SSRI) of the amphetamine family (specifically, a derivative of phentermine, and closely related to chlorphentermine, a highly selective serotonin releasing agent) that was investigated as an antidepressant for the treatment of depression, anxiety disorders, and anorexia nervosa by Jouveinal but did not complete development and was never marketed.[1][2][3][4] It reached phase III clinical trials in 1996 before development was discontinued in 1999.[5]

Synthesis

Cericlamine synthesis:[6]

Arylation of methacrylic acid with a diazonium salt of 3,4-dichloroaniline (or 3,4-dichloro-benzenediazonium salt), is carried out according to the Meerwein reaction catalysed by a metallic halide. For the next step, the halide is displaced by dimethylamine, then esterification is performed, followed by reduction with a metal hydride.

See also

References

  1. 1 2 3 Darcourt, G.; Tessera, M.; Lesaunier, R.; Engrand, P.; Scherrer, B.; Dreyfus, J. F.; Bogaievsky, Y. (1992). "A MULTICENTRE DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING STUDY WITH CERICLAMINE IN MAJOR DEPRESSION.". Clinical Neuropharmacology 15: 176B. doi:10.1097/00002826-199202001-00339. ISSN 0362-5664.
  2. ↑ Crow, Scott; Brown, Eric (2003). "Investigational drugs for eating disorders". Expert Opinion on Investigational Drugs 12 (3): 491–499. doi:10.1517/13543784.12.3.491. ISSN 1354-3784.
  3. ↑ Ramesh N. Patel (3 January 2000). Stereoselective Biocatalysis. CRC Press. pp. 48–. ISBN 978-0-8247-8282-5.
  4. ↑ Lily C. Tang; Stephen J. Tang (6 December 2012). Neurochemistry in Clinical Application. Springer Science & Business Media. pp. 81–. ISBN 978-1-4615-1857-0.
  5. ↑ AdisInsight. "Cericlamine". Retrieved 13 January 2016.
  6. ↑ U.S. Patent 6,121,491



This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.